These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36548708)

  • 1. Comment on Lachin et al. Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications Trial. Diabetes Care 2022;45:2445-2448.
    Ceriello A; Prattichizzo F
    Diabetes Care; 2023 Jan; 46(1):e12. PubMed ID: 36548708
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to Comment on Lachin et al. Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications Trial. Diabetes Care 2022;45:2445-2448.
    Lachin JM; Bebu I; Gao X; Nathan DM; Zinman B
    Diabetes Care; 2023 Jan; 46(1):e13. PubMed ID: 36548707
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment on Lachin et al. Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial. Diabetes Care 2017;40:777-783.
    Fleischer J; Cichosz SL; Hansen TK
    Diabetes Care; 2017 Nov; 40(11):e164. PubMed ID: 29061593
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to Comment on Lachin et al. Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial. Diabetes Care 2017;40:777-783.
    Lachin JM; Bebu I; Bergenstal RM; Pop-Busui R; Service FJ; Zinman B; Nathan DM;
    Diabetes Care; 2017 Nov; 40(11):e165-e166. PubMed ID: 29061594
    [No Abstract]   [Full Text] [Related]  

  • 5. Comment on: Lachin et al. (2007) The hemoglobin glycation index is not an independent predictor of the risk of microvascular complications in the diabetes control and complications trial: Diabetes 56:1913-1921, 2007.
    Chalew S; Hempe J; McCarter R
    Diabetes; 2008 Feb; 57(2):e4; author reply e5. PubMed ID: 18227521
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications Trial.
    Lachin JM; Bebu I; Gao X; Nathan DM; Zinman B;
    Diabetes Care; 2022 Oct; 45(10):2445-2448. PubMed ID: 35972222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycated hemoglobin variability and microvascular complications in patients with type 1 diabetes mellitus.
    Er E; Ata A; Evin F; Altınok YA; Demir G; Özen S; Darcan Ş; Gökşen D
    J Pediatr Endocrinol Metab; 2020 Dec; 33(12):1533-1537. PubMed ID: 33581707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood glucose control and microvascular and macrovascular complications in diabetes.
    Hanssen KF
    Diabetes; 1997 Sep; 46 Suppl 2():S101-3. PubMed ID: 9285509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hemoglobin glycation index is not an independent predictor of the risk of microvascular complications in the Diabetes Control and Complications Trial.
    Lachin JM; Genuth S; Nathan DM; Rutledge BN
    Diabetes; 2007 Jul; 56(7):1913-21. PubMed ID: 17360979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial.
    Lachin JM; Bebu I; Bergenstal RM; Pop-Busui R; Service FJ; Zinman B; Nathan DM;
    Diabetes Care; 2017 Jun; 40(6):777-783. PubMed ID: 28404658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Effects of Continuous Subcutaneous Insulin Infusion on Glucose Control and Microvascular Complications in Patients With Type 1 Diabetes.
    Marchand L; Kawasaki-Ogita Y; Place J; Fayolle C; Lauton D; Boulet F; Farret A; Renard E
    J Diabetes Sci Technol; 2017 Sep; 11(5):924-929. PubMed ID: 28303725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HbA
    Metcalf PA; Kyle C; Kenealy T; Jackson RT
    J Diabetes Complications; 2017 May; 31(5):814-823. PubMed ID: 28319002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin autofluorescence is associated with past glycaemic control and complications in type 1 diabetes mellitus.
    Genevieve M; Vivot A; Gonzalez C; Raffaitin C; Barberger-Gateau P; Gin H; Rigalleau V
    Diabetes Metab; 2013 Sep; 39(4):349-54. PubMed ID: 23643347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic control in diabetes mellitus: have changes in therapy made a difference?
    Nathan DM; McKitrick C; Larkin M; Schaffran R; Singer DE
    Am J Med; 1996 Feb; 100(2):157-63. PubMed ID: 8629649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between HbA1c Variability and Risk of Microvascular Complications in Adolescents With Type 1 Diabetes.
    Virk SA; Donaghue KC; Cho YH; Benitez-Aguirre P; Hing S; Pryke A; Chan A; Craig ME
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3257-63. PubMed ID: 27186858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A 20-year prospective follow-up study to evaluate the development of retinopathy and nephropathy after the onset of type 1 diabetes mellitus: Contribution of glycemic control and metabolic memory].
    Bolotskaya LL; Bessmertnaya EG; Shestakova MV; Shamkhalova MS; Nikankina LV; Ilyin AV; Glek IS; Zolotukhin AV; Dedov II
    Ter Arkh; 2017; 89(10):17-21. PubMed ID: 29171465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between early glycemic management and diabetes complications in type 1 diabetes mellitus: A retrospective cohort study.
    Suh J; Choi Y; Oh JS; Song K; Choi HS; Kwon A; Chae HW; Kim HS
    Prim Care Diabetes; 2023 Feb; 17(1):60-67. PubMed ID: 36609067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview.
    Nathan DM;
    Diabetes Care; 2014; 37(1):9-16. PubMed ID: 24356592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body mass index, estimated glucose disposal rate and vascular complications in type 1 diabetes: Beyond glycated haemoglobin.
    Helliwell R; Warnes H; Kietsiriroje N; Campbell M; Birch R; Pearson SM; Ajjan RA
    Diabet Med; 2021 May; 38(5):e14529. PubMed ID: 33502032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glycemic variability and microvascular complications of diabetes].
    Prázný M; Škrha J; Šoupal J; Škrha J
    Cas Lek Cesk; 2017; 156(6):308-313. PubMed ID: 29212335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.